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Abstract
Background: To determine the ocular changes related to hypothyrodism in newly diagnosed
patients without orbitopathy.
Findings: Thirty-three patients diagnosed to have primary overt hypothyroidism were enrolled in
the study. All subjects were assigned to underwent central corneal thickness (CCT), anterior
chamber volume, depth and angle measurements with the Scheimpflug camera (Pentacam, Oculus)
and cup to disc ratio (C/D), mean retinal thickness and mean retinal nerve fiber layer (RNFL)
thickness measurements with optical coherence tomography (OCT) in addition to
ophthalmological examination preceeding the replacement therapy and at the 1st, 3rd and 6th
months of treatment.
The mean age of the patients included in the study were 40.58 ± 1.32 years. The thyroid hormone
levels return to normal levels in all patients during the follow-up period, however the mean
intraocular pressure (IOP) revealed no significant change. The mean CCT was 538.05 ± 3.85 μ
initially and demonstrated no statistically significant change as the anterior chamber volume, depth
and angle measurements did. The mean C/D ratio was 0.29 ± 0.03 and the mean retinal thickness
was 255.83 ± 19.49 μ initially and the treatment did not give rise to any significant change. The mean
RNFL thickness was also stable during the control visits, so no statistically significant change was
encountered.
Conclusions: Neither hypothyroidism, nor its replacement therapy gave rise to any change of
IOP, CCT, anterior chamber parameters, RNFL, retinal thickness and C/D ratio.
Introduction
The eye is a unique sensory organ that is prone to the
effects of various systemic disorders. Hypothyroidism is
one of these, presenting frequently with chemosis, perior-
bital edema and blepharoptosis. These changes, described
as orbitopathy are attributed to the accumulation of
hydrophilic mucopolysaccharides in the ground sub-
stance of dermis and other tissues leading to thickening
which is called myxoedema [1].
Another proposed, ocular finding of hypothyroidism is
the intraocular pressure (IOP) rise. There has been a
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number of reports regarding the higher prevalance of pri-
mary open angle glaucoma (POAG) among hypothyroid
individuals, however contoversy stil exists as some others
have failed to demonstrate this [2-5]. In a study of Smith
et al [2] 23.4% of POAG patients had hypothyroidism. As
they noted decrease of IOP with treatment of hypothy-
roidism in a patient with POAG, IOP rise was attributed to
the reduction in facility of outflow in the hypothyroid
state [6,7]. Another study of Centanni et al [8] demon-
strated a reversible increase of IOP even in subclinical
hypothyroidism which raised the question about whether
some microscopic findings precede the macroscopic signs
of hypothyroidism. The study of Bahçeci et al [9] sup-
ported this further by demonstrating a reversible increase
of the central corneal thickness (CCT) which lead to a
reversible IOP rise and a decreased CCT correlated with
the decrease of thyroid-stimulating hormone (TSH).
In an attempt to elucidate the precise effect of hypothy-
roidism on ocular structures including cornea, anterior
chamber, lens and retina, we conducted a study on newly
diagnosed, overt hypothyroid patients without orbitopa-
thy comparing the pre- and postreplacement findings.
Materials and methods
This prospective, single-center, clinical study was con-
ducted at the department of Ophthalmology, Selcuk Uni-
versity, Meram Faculty of Medicine with the collaboration
of the department of Endocrinology. Sixtysix eyes of 33
patients who were diagnosed to have acquired primary
hypothyroidism in the outpatient clinic of the Endo-
crinology department were enrolled in the study. The ini-
tial ophthalmological examination was conducted
preceding the reatment of hypothyroidism to exclude any
history or finding of an ocular disease and for the
approval of the informed consent. A complete ophthal-
mic examination including visual acuity, IOP with Gold-
mann applanation tonometer, anterior segment and
fundus examination was performed and patients with any
sign of orbitopathy, corneal pathology, glaucoma and ret-
inal vascular disease were excluded from the study. Eligi-
ble patients were assigned to undergo CCT, anterior
chamber volume, depth and angle with the Scheimpflug
camera (Pentacam, Oculus) in addition to cup to disc
ratio (C/D), retinal thickness and retinal nerve fiber layer
(RNFL) thickness measurements with optical coherence
tomography [(OCT), (Stratus OCT-3) Carl Zeiss Meditec,
Inc., CA]. After pupillary dilatation, fast optic disc and fast
RNFL scans were performed by OCT. C/D ratios were
recorded after optic disc analysis was carried out. The ret-
ina thickness in the superior, nasal, inferior and temporal
quadrants, calculated automatically by OCT device were
recorded and average RNFL thickness values are obtained
from the retinal nerve fiber analysis of OCT.
Control visits were scheduled for the first, 3rd and 6th
months after initiation of the medical therapy for
hypothyrodism and included the same ophthalmic exam-
ination procedures performed initially together with Pen-
tacam and OCT measurements following control
examination in the outpatient clinic of the Endocrinology
department and thyroid hormone level measurements
including thyroid-stimulating hormone (TSH), free T3
and free T4 in the clinic of endocrinology. To avoid the
effect of diurnal and personel changes, both the inital
examination and control visits were performed at the
same time in the morning and by the same doctor (BTO).
The data was analyzed by using the Statistical Package for
Social Science (SPSS) programme (Worldwide Headquar-
ters SPSS Inc. 15.0 Windows package program). According
to the normality tests, parameters showing a normal dis-
tribution were analyzed using the repeated measures test
and the remaining parameters showing an abnormal dis-
tribution were analyzed using the nonparametric k related
sample test. Additionally the correlation of the TSH
change with all of the study parameters were analyzed by
Pearson correlation test and Spearman's correlation test
depending on the distribution type of the data. As TSH
has been demonstrated to be an excellent screening test
for hypothyroidism correlation with thyroid hormones
has not been analyzed [1]. A p value of < 0.05 was consid-
ered as statistically significant.
Results
Sixty-six eyes of 32 female patients and 1 male patient
who was diagnosed to have primary clinical hypothy-
roidism and completed the sixth month follow-up pro-
gram were enrolled in the study. The mean age was 40.58
± 1.32 years ranging between 19-61 years. The initial
mean TSH level of 16.02 ± 2.38 μIU/ml decreased to 3.36
± 0.54 μIU/ml at the end of the sixth months, while mean
free T3 level increased from 2.21 ± 0.19 pg/ml to 4.05 ±
0.07 pg/ml and mean free T4 level achieved a normal level
of 1.06 ± 0.06 ng/dl by ascending from the initial level of
0.57 ± 0.02 ng/dl (Table 1). Hypothyroidism was related
to Hashimoto thyroiditis in 15 out of 33 patients.
The IOP measured at each control visit was within normal
limits in all patients except one patient. She was diag-
nosed to have ocular hypertension and warranted use of
both timolol acetate and dorzolamide hydrochloride.
This patient was discarded during the mean IOP calcula-
tions. The mean IOP was 14.40 ± 2.45 mmHg initially,
14.42 ± 2.76 at the first month, 14.22 ± 2.97 mHg at the
third month and 14.69 ± 2.17 mmHg at the 6th month
control. These measurements were also analysed statisti-
cally, but any significant IOP decrease with treatment was
lacking (p = 0.23) and IOP measurements was not corre-
lated with the decrease in TSH (p = 0,10).BMC Research Notes 2009, 2:266 http://www.biomedcentral.com/1756-0500/2/266
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The mean CCT obtained via Pentacam Scheimpflug cam-
era was 538.05 ± 31.29 μ before the treatment. It demon-
strated a slight decrease at the end of the first month of
therapy, followed by a slight increase at the 3rd month
control and remained quite stabile at the 6th month con-
trol at a level of 537.64 ± 33,37 μ. Statistical analysis
revealed no significant change of the CCT (p = 0.82). The
mean anterior chamber depth changed from the initial
level of 2.90 ± 0.38 mm to 2.89 ± 0.38 mm at the end of
the first month, 2.89 ± 0.38 mm at the third month con-
trol and 2.87 ± 0.30 mm at the sixth month control. This
gradual decrease was also found to be statistically insignif-
icant (p = 0.31). In contrast, both the mean volume of
anterior chamber which was 159.67 ± 43.91 mm3 at the
beginning and the mean anterior chamber angle meas-
ured as 35.76 ± 7.58° at the initial visit demonstrated var-
iation. However the statistical analysis revealed no
significant change for both parameters (p = 0,53, p = 0.86,
respectively) (Table 2).
The correlation between the change of the TSH level and
the change of the CCT, anterior chamber depth, volume
and angle was evaluated by comparing the initial and the
final (6th month) measurements however no significant
correlation could be estimated (p = 0.43, p = 0.31, p =
0.40, p = 0.49 respectively).
The mean retinal thickness, mean RNFL thickness and the
mean C/D ratio was 255.83 ± 19.49 μ, 97.71 ± 1.83 μ and
0.29 ± 0.03 respectively at the beginning of the study and
no significant change could be detected after treatment
according to the statistical analysis (p = 0.79, p = 0.68, p =
0.43, respectively) (Table 3). The correlation of retinal
thickness, RNFL thickness and C/D ratio measurement
with the decrease of TSH was also insignificant (p = 0.14,
p = 0.13, p = 0.39)
Discussion
Thyroid hormone plays a pivotal role in the neural devel-
opment of the eye especially for normal development of
retina and attainment of color vision. It regulates intrinsic
mechanisms for controlling retinal cytoarchitecture and
layering [10]. As Gamborino et al. [11] demonstrated in a
rat model, the photoreceptor and ganglion cell layer thick-
ness displayed significantly lower values in congenital-
neonatal hypothyroidism. In contrast acquired deficiency
of thyroid hormones is reported to mainly affect the IOP
beside findings of orbitopathy like periorbital edema and
chemosis related to myxedema [1].
The first reports regarding the IOP increase in hypothy-
roidism are dating back to 1897 and has been ascribed to
hypothalamic disturbance either directly or via the pitui-
tary gland acting on the thyroid and the eye at the same
time and glaucoma has been associated at times with thy-
rotoxicosis and at times with myxoedema. Another specu-
lation of Cheng & Perkins is the genetic predisposition to
both conditions [12]. In 1965, McLenachan and Davies
postulated that the deposition of glycosaminoglycan in
trabecular meshwork might lead to a decrease of aqueus
humor outflow [13], however it has not been demon-
strated so far. Later Becker et al [14] raised the question
whether hypothyroidism induce myxedema of the trabec-
ular meshwork and Smith et al [15] proposed vasculopa-
thy altering ocular bloodflow as the mechanism of IOP
increase in hypothyroidism. The glycosaminoglycan dep-
Table 1: Pre- and posttreatment thyroid hormone levels
Pretreatment 1st Month 3rd Month 6th Month Normal range
TSH (μIU/ml) 16.02 ± 2.38 6.63 ± 0.83 4.14 ± 0.70 3.36 ± 0.54 0.4-4.0
Free T3 (pg/ml) 2.21 ± 0.19 3.45 ± 0.14 3.85 ± 0.19 4.05 ± 0.07 1.57-4.71
Free T4 (ng/dl) 0.57 ± 0.02 0.75 ± 0.03 1.02 ± 0.07 1.06 ± 0.06 0.8-1.90
Table 2: Change of the follow-up parameters measured with Pentacam Scheimpflug camera at control visits
Pretreatment 1st Month 3rd Month 6th Month p
Central corneal thickness (μ) 538.04 ± 31.29 536.95 ± 32.33 537.04 ± 32.86 537.64 ± 33.37 0.82
Anterior chamber depth (mm) 2.90 ± 0.38 2.89 ± 0.38 2.89 ± 0.38 2.87 ± 0.40 0.31
Anterior chamber volume (mm3) 159.67 ± 43.91 155.32 ± 45.43 159.38 ± 41.88 158.62 ± 44.28 0.53
Anterior chamber angle (°) 35.76 ± 7.58 35.15 ± 7.01 35.20 ± 7.63 35.41 ± 7.61 0.86BMC Research Notes 2009, 2:266 http://www.biomedcentral.com/1756-0500/2/266
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osition in trabecular meshwork seems to gain most atten-
tion among these, though it could not been demonstrated
histopathologically so far.
The literature contains a number of conflicting reports [2-
4,15] that determine the incidence of hypothyroidism
among POAG patients to decide whether screening of thy-
roid hormones are necessary for open-angle glaucoma
patients or not. Smith et al [2] and Girkin et al [4] found
a high incidence of hypothyroidism among subjects with
POAG, whereas Gillow [15] and Munoz-Negrete [3] failed
to show any evidence of a clinically important association
between hypothyroidism and glaucoma as Cheng and
Perkins [13].
Other type of studies designed to estimate the prevalance
of open-angle glaucoma in acquired hypothyroidism
patients found no relationship between these disorders,
except Tahat et al [16] who reported a positive relation-
ship, though only 3 of 60 patients was diagnosed to have
glaucoma. Karadimas et al [5] examined 100 hypothyroid
patients and none of them had glaucoma. In our study, we
found ocular hypertension in only one patient. As it is to
our knowledge glaucoma incidence increases over 40
years [17]. Studies evaluating the incidence of hypothyro-
dism among glaucoma patients have usually older age
ranges, in contrast studies designed to determine the inci-
dence of glaucoma among hypothyroid patients have
younger subjects which may explain the lower glaucoma
incidence found in this type of studies including ours.
As estimating only the prevalance of glaucoma may cause
to overlook the true effect of hypothyroidism on IOP
because changes under 21 mmHg would not be taken into
account; we investigated the correlation of IOP with the
change of TSH and found no decrease of IOP parallel to
the decrease of TSH with treatment. Bahçeci et al [9]
found significant decrease of IOP with treatment, however
it was also not correlated with the changes in the thyroid
hormone levels. They also reported a significant decrease
of CCT after replacement therapy and stated that these
reversible changes may be related to mucopolysaccharide
deposition in corneal stroma as corneal thickness
decreased following the replacement therapy, however
the mean CCT revealed no significant change in our study.
Both studies included newly detected hypothyroid
patients however the period of hypothyroidism is
unknown and the method for corneal thickness measure-
ments are different. Bahceci et al used ultrasonic pachym-
etry while we used the Scheimpflug camera. These may be
an explanation of the conflicting results.
In our study we aimed to sort out the effect of hypothy-
roidism on ocular tissues including cornea, anterior
chamber, lens and retina in search for an answer to these
contradictory results and evaluated the pre- and posttreat-
ment measurements of the anterior chamber depth, vol-
ume, angle of hypothyroid patients. The initial
measurements were not significantly different from the
ones at the 1st, 3rd and 6th months of replacement ther-
apy. This finding may be explained by the lack of orbitop-
athy and unknown duration of the disease. However as
our study is the first evaluating these parameters, further
studies comparing these findings with that of the
hypothyroid patients with orbitopathy are necessary.
The changes in RNFL thickness, C/D ratio and retinal
thickness were also evaluated in this study and found
steady in all measurements during the follow-up period.
In the literature RNFL thickness of hypothyroid patients
was obtained just in the study of Bahçeci et al [9] and they
also found no change in RNFL thickness between pretreat-
ment and postreplacement measurements.
Conclusions
Regarding these findings together, this survey suggest that
a direct influence of thyroid hormones on ocular struc-
tures is unlikely. Though the unknown period of the
hypothyroid state, the younger mean age and lack of orbi-
topathy might be responsible for the conflicting results, it
may also support the speculation about the predisposi-
tion of individuals with inclination to auto-immunity to
several diseases including hypothyroidism and glaucoma
[18]. Further studies evaluating hypothyroid patients
according to etiology (Hashimoto disease, Graves dis-
ease), period of the disease and presence of orbitopathy
seperately may enlighten this dilemma.
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